HCPCS Code Descriptor:
Injection, guselkumab, 1 mg
Route of Administration:
TREMFYA is an Immunology:Anti-TNF drug manufactured by Janssen and administered via the Subcutaneous route of administration. The J Code: J1628 is aligned to the drug TREMFYA.
Tremfya is a monoclonal antibody that is used to treat certain skin and joint conditions. It works by blocking a certain protein which causes immune responses and is administered via subcutaneous injection. Tremfya is a branded drug manufactured by Janssen Biotech. Prior to receiving its J Code: J1628 in January 2019, Tremfya was aligned to the C Code: C9029.Patient assistance programs for Tremfya can be found through the Johnson & Johnson Patient Assistance Program.